Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR study.

MLA

Menzies-Gow, Andrew, et al. “Effect of Tezepelumab on Healthcare Utilization in Patients with Severe, Uncontrolled Asthma: The NAVIGATOR Study.” Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology, vol. 131, no. 3, Sept. 2023, p. 343. EBSCOhost, https://doi.org/10.1016/j.anai.2023.05.028.

APA

Menzies-Gow, A., Bourdin, A., Chupp, G., Israel, E., Hellqvist, Å., Hunter, G., Roseti, S. L., Ambrose, C. S., Llanos, J.-P., Cook, B., Corren, J., & Colice, G. (2023). Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR study. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology, 131(3), 343. https://doi.org/10.1016/j.anai.2023.05.028

Chicago

Menzies-Gow, Andrew, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel, Åsa Hellqvist, Gillian Hunter, Stephanie L Roseti, et al. 2023. “Effect of Tezepelumab on Healthcare Utilization in Patients with Severe, Uncontrolled Asthma: The NAVIGATOR Study.” Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology 131 (3): 343. doi:10.1016/j.anai.2023.05.028.